Home » Topics » BioWorld Science

BioWorld Science
RSS

Multifunctional carbazole-based dopamine agonists for the treatment of Parkinson's disease

Feb. 11, 2019

Ganglioside analogue modulates APP processing and function rescuing neurodegeneration in AD

Feb. 11, 2019

Discovery and preclinical characterization of novel pan-PIM kinase inhibitor

Feb. 11, 2019

Orally active GPR119 agonist demonstrates hypoglycemic effects in rats

Feb. 11, 2019

Chronic inflammation leads to 'immunological scarring'

Feb. 11, 2019

Antidepressant also fights sepsis

Feb. 11, 2019

Gene therapy found effective in a mouse model of Fabry disease

Feb. 11, 2019

Mosquito diet drugs could block spread of multiple diseases

Feb. 11, 2019

Sanofi to seek new partner for ophthalmology gene therapies SAR-422459 and SAR-421869

Feb. 8, 2019

Chinese researchers disclose EGFR inhibitors

Feb. 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...